Literature DB >> 18320356

Promoter sequence variants of LIGHT are associated with female vascular dementia.

Minyoung Kong1, Younyoung Kim, Chaeyoung Lee.   

Abstract

LIGHT (homologous to L ymphotoxins, exhibits I nducible expression, and competes with herpes simplex virus G lycoprotein D for H erpes virus entry mediator, a receptor expressed by T lymphocytes) is implicated in the inflammation by disrupted T cell homeostasis, primarily at a transcriptional level. We investigated the association of LIGHT promoter with ischemic stroke and vascular dementia induced by such inflammation. We determined transcription factor binding sites altered by promoter SNPs using transcription factor prediction programs. Six common haplotypes composed of the selected SNPs (C-770T, G-607T, G-543A, and A-399G) were used for the assay of reporter activity. The most frequent haplotype construct, CGGA, induced the highest luciferase activity. The haplotype TTGA showed the lowest expression with 0.39-fold activity (P < 0.001) of CGGA. The substitution from C to T at the locus of C-770T (TGGA) decreased the reporter activity by 47% (P < 0.001). The SNPs and haplotypes were further investigated to see their association with ischemic stroke and vascular dementia in 455 controls and 478 patients. Significant association with vascular dementia was shown in the allele T of C-770T (odds ratio [OR] = 1.54; P < 0.05) and the haplotype TTGA (OR = 10.59; P < 0.05) in females. We concluded that the allele T of C-770T and the haplotype TTGA of the promoter SNPs in LIGHT gene might decrease the expression of LIGHT and subsequently increase the susceptibility to vascular dementia in females.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18320356     DOI: 10.1007/s11373-008-9242-2

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  3 in total

1.  Polymorphic variants of LIGHT (TNF superfamily-14) alter receptor avidity and bioavailability.

Authors:  Timothy C Cheung; Ken Coppieters; Hideki Sanjo; Lisa M Oborne; Paula S Norris; Amy Coddington; Steven W Granger; Dirk Elewaut; Carl F Ware
Journal:  J Immunol       Date:  2010-06-30       Impact factor: 5.422

Review 2.  Tumor necrosis factor superfamily in innate immunity and inflammation.

Authors:  John Šedý; Vasileios Bekiaris; Carl F Ware
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-12-18       Impact factor: 10.005

3.  Human genetic evidence for involvement of CD137 in atherosclerosis.

Authors:  Leif Å Söderström; Karl Gertow; Lasse Folkersen; Maria Sabater-Lleal; Eva Sundman; Yuri Sheikine; Anuj Goel; Damiano Baldassarre; Steve E Humphries; Ulf de Faire; Hugh Watkins; Elena Tremoli; Fabrizio Veglia; Anders Hamsten; Göran K Hansson; Peder S Olofsson
Journal:  Mol Med       Date:  2014-10-14       Impact factor: 6.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.